Citation Impact
Citing Papers
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
MANAGEMENT OF DIABETIC FOOT INFECTIONS, INCLUDING THE USE OF HOME INTRAVENOUS ANTIBIOTIC THERAPY
1996
Lower Extremity Revascularization in Diabetes
2000
A Flexible Approach to Infrapopliteal Vein Grafts in Patients With Diabetes Mellitus
1991
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
1999 StandoutNature
THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS
1996
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin
2005 Standout
Classification of diabetic foot wounds
1996
Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain
1990 StandoutNobel
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Wound healing and its impairment in the diabetic foot
2005 Standout
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
1999 StandoutNature
Antibiotic beads in the treatment of diabetic pedal osteomyelitis
2000
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
The metabolic syndrome
2010 Standout
Cerebrovascular disease associated with sickle cell pulmonary hypertension
2006
Osteomyelitis
1997 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Outcomes of preventative care in a diabetic foot specialty clinic
1998
Uric Acid and Cardiovascular Risk
2008 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
An evidence-based approach to diabetic foot infections
2003
Pharmacotherapy for critical limb ischaemia
2000
The burden of diabetic foot ulcers
1998
Improved Quality of Diabetic Foot Care, 1984 vs 1990
1993
New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor
1994 StandoutNatureNobel
Platelet Activation and Atherothrombosis
2007 Standout
The metabolic syndrome
2005 Standout
Diabetes and Atherosclerosis
2002 Standout
The role of nitric oxide in mediating non-adrenergic non-cholinergic relaxation in longitudinal muscle of human taenia coli
1992
The L-Arginine-Nitric Oxide Pathway
1993 Standout
Comparison of three systems of classification in predicting the outcome of diabetic foot ulcers in a Brazilian population
2008
Diabetic foot ulcers
2003 Standout
Infections in Patients with Diabetes Mellitus
1999 Standout
Oral Beraprost Sodium, a Prostaglandin I 2 Analogue, for Intermittent Claudication
2000
The chronic wound: impaired healing and solutions in the context of wound bed preparation
2003
Sickle-cell disease
2010 Standout
Healing rates of plantar ulcers in leprosy and diabetes
1992
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Classification of wounds of the diabetic foot
2001
Deep Foot Infections in Patients with Diabetes and Foot Ulcer
1999
Diabetic Foot Disorders: A Clinical Practice Guideline (2006 Revision)
2006 Standout
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Alzheimer's Disease
2010 Standout
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.
1998 Standout
Nitric oxide in the pathogenesis of vascular disease
2000
Mammalian Nitric Oxide Synthases
1992
Microcirculation of the Diabetic Foot
2005
Pulmonary Complications of Sickle Cell Disease
2008
Trends in the Care of the Diabetic Foot
1992
Assessment and Management of Foot Disease in Patients with Diabetes
1994 Standout
Wound healing: Biologic features and approaches to maximize healing trajectories
2001
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
Endothelium-Derived Nitric Oxide: Pharmacology and Relationship to the Actions of Organic Nitrate Esters
1989 StandoutNobel
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
2015 Standout
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
2006
Overview: Purinergic Mechanisms
1990
NITRERGIC TRANSMISSION: NITRIC OXIDE AS A MEDIATOR OF NON‐ADRENERGIC, NON‐CHOLINERGIC NEURO‐EFFECTOR TRANSMISSION
1992
RAGE Mediates a Novel Proinflammatory Axis
1999 Standout
The PACK Trial: Morbidity and Mortality Effects of Ketanserin
1996
Antioxidant Vitamin C Improves Endothelial Function in Obstructive Sleep Apnea
2006
Biochemistry of Nitric Oxide and Its Redox-Activated Forms
1992 StandoutScience
Diabetes and peripheral vascular disease
1999
The effect of a nicotine containing chewing gum on the coagulation system in normal volunteers
1984
Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review
2020
The Effect of Ciprostene in Patients with Peripheral Vascular Disease (PVD) Characterized by Ischemic Ulcers
1991
Endothelium-derived relaxing factors
1995
Diabetic foot ulcers: prevention, diagnosis and classification.
1998
Studies of controlled reperfusion after ischemia
1990
Type 2 diabetes: principles of pathogenesis and therapy
2005 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review
2015
Lymphokine stimulation of collagen accumulation.
1976
Current and Future Drug Therapies for Claudication
1997
Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages
1992 StandoutScience
An Audit of Foot Infections in Patients with Diabetes Mellitus Following Renal Transplantation
2004
Myocardial temperature management during aortic clamping for cardiac surgery
1991
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
High-Dose Allopurinol Improves Endothelial Function by Profoundly Reducing Vascular Oxidative Stress and Not by Lowering Uric Acid
2006
Diabetic Foot Infections
1991
Highly sensitive electrochemical determination of nitric oxide using fused spherical gold nanoparticles modified ITO electrode
2010
The Dysvascular Foot: A System for Diagnosis and Treatment
1981 Standout
Cilostazol Has Beneficial Effects in Treatment of Intermittent Claudication
1998
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Improving Drug-Therapy Decisions through Educational Outreach
1983 Standout
Adventures in vascular biology: a tale of two mediators
2006
Diagnosis and Treatment of Diabetic Foot Infections
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Lower Extremity Arterial Reconstruction in Patients With Diabetes Mellitus
2006
The system of care for the diabetic foot: objectives, outcomes, and opportunities
2013
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Scientific versus commercial sources of influence on the prescribing behavior of physicians
1982
Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion
1980
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Safety of prolonged aortic clamping with blood cardioplegia
1986
THE EFFECT OF ANTI‐INFLAMMATORY DRUGS ON VASCULAR SMOOTH MUSCLE
1967
Dermal Neurovascular Dysfunction in Type 2 Diabetes
2001
BACTERIOLOGY OF DIABETIC FOOT LESIONS
2004
Release of renal prostaglandins during endotoxin-induced hypotension
1976 StandoutNobel
Purification of a soluble isoform of guanylyl cyclase-activating-factor synthase.
1991 StandoutNobel
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.
1986 Standout
Works of Jay D. Coffman being referenced
Chronic Inhibition of Nitric Oxide Production Augments Skin Vasoconstriction in the Rabbit Ear
1993
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels
2003
Failure of Vasodilator Drugs in Arteriosclerosis Obliterans
1972
Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium
1989
Vasodilator Drugs in Peripheral Vascular Disease
1979
Capillary Permeability and Blood Flow in Skeletal Muscle of Patients with Diabetes Mellitus and Genetic Prediabetes
1972
α-Adrenergic and Serotonergic Mechanisms in the Human Digit
1988
Skin blood flow in scleroderma.
1970
Oxygen metabolism and oxygen debt repayment after myocardial ischemia
1961
Vascular and Microvascular Disease of the Foot in Diabetes
1984
The attenuation by reserpine or guanethidine of the cutaneous vasoconstriction caused by tobacco smoking
1967
Pharmacological Concentrations of Ascorbic Acid Are Required for the Beneficial Effect on Endothelial Vasomotor Function in Hypertension
2000
Intermittent claudication: Not so benign
1986
Effect of aspirin on circulatory responses to catecholamines
1963